Syncom Formulations (India) Limited Reported Its Excellent Performance For 4th Quarter

Mumbai (Maharashtra) [India], June 2: Syncom Formulation ( India ) Ltd , a Speciality Pharmaceutical Formulation company Today reported its excellent performance for 4th quarter and year ended 31st March 25. 

Q4 FY2025 Performance highlights (compared to Q4 FY2024): 

• Revenue from operations at Rs.14888 Lacs against Rs.7457 Lacs.; up 100%. 
• EBITDA at Rs.2469 Lacs against Rs.1252 Lacs; Up 97%; 
• Profit after tax at Rs.1769 Lacs against Rs.740 Lacs.; Up 139%;

FY 2025 Performance highlights (compared to FY2024): 

• Revenue from…